Karen Leroy

Karen Leroy

Equipe 09, Université Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.

End-of-life management and causes of death in ALK-positive non-small cell lung cancer in France: a multicentric analysis.

Journal: Translational lung cancer research

Published: March 27, 2026

Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experience.

Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experience.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 02, 2025

TLR7 induces autophagy in non-small cell lung cancer tumor cells and influences anti-tumors responses in patients.

TLR7 induces autophagy in non-small cell lung cancer tumor cells and influences anti-tumors responses in patients.

Journal: Translational lung cancer research

Published: October 15, 2025

Genetic variant interpretation in tumours in the French national ring trials Gen&Tiss - main criteria of improvement.

Genetic variant interpretation in tumours in the French national ring trials Gen&Tiss - main criteria of improvement.

Journal: Virchows Archiv : an international journal of pathology

Published: September 05, 2025

Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial.

Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 04, 2025

ALK rearrangement in non-small cell lung cancer

ALK rearrangement in non-small cell lung cancer

Journal: Bulletin du cancer

Published: March 28, 2025

Molecular characterization of lung cancers: up-date and recommendations

Molecular characterization of lung cancers: up-date and recommendations

Journal: Bulletin du cancer

Published: March 28, 2025

Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.

Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.

Journal: Nature communications

Published: March 07, 2025

Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy.

Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: September 20, 2024

MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience.

MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience.

Journal: Scientific reports

Published: June 03, 2024

Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.

Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.

Journal: Translational lung cancer research

Published: April 11, 2024

Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinoma.

Clinical and molecular characteristics associated with high PD-L1 expression in EGFR-mutated lung adenocarcinoma.

Journal: PloS one

Published: January 21, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026